Abstract:
Methods and apparatus for guidance systems according to various aspects of the present invention operate in conjunction with a projectile including a guidance system having a guidance controller, a detector, and an optical system. The guidance controller controls the path of the projectile according to signals from the detector. The detector generates signals according to an angle of incident energy. The optical system transfers the energy to the detector via a spreader and a condenser. The spreader spreads the incident energy, and the condenser converges the spread energy onto the detector.
Abstract:
An improved protein beverage which may provide a relatively high protein content, ranging from about 0.01% by weight to about 15% by weight, while optionally employing a carbonation concentration between about 0.1 volumes of carbonation (per volume of liquid drink) to about 6 volumes of carbonation. Preferably the protein is a protein, such preferably as whey protein, or others. The protein beverage may contain juice and/or an additive which provides energy generation enhancement. The protein beverage may be heat treated to inactivate pathogenic microbes in the presence of the carbonation which may be used to provide taste and mouth feel for the drink. Typically, the treatment for pathogenic microbe inactivation is carried out in the individual package used for storage and handling of the protein drink. The protein beverage may be prepared from a protein beverage concentrate, which may be in the form of a syrup concentrate or a powder concentrate.
Abstract:
A sensor system according to various aspects of the present invention comprises a sensor viewing an area via an optical path and a strut at least partially interposed across the viewing area. The strut is configured to taper along the optical path towards the sensor. In an exemplary embodiment, the strut includes at least two sides forming an angle along their common edge exposed to the sensor along the optical path.
Abstract:
A fluid ejection device includes a fluid chamber, a fluid restriction communicated with the fluid chamber, and a fluid channel communicated with the fluid restriction. The fluid restriction has a fluid restriction parameter defined as (2*W+2*H)*L/(H*W), wherein W is a width of the fluid restriction, H is a height of the fluid restriction, and L is a length of the fluid restriction. As such, the fluid restriction parameter is in a range of 1.5 to 5.75.
Abstract:
A network design that reduces the number of wavelengths needed to support communications in a Wavelength Division Multiplexing (WDM) network is disclosed. Wavelengths are reused in isolated sub-networks that do not share common network paths, allowing for the reduction in cost of the WDM equipment supporting the communications in the network.
Abstract:
The invention concerns an organometallic compound of formula RO-M(L1)X (L2)Y (L3)Z wherein M is a metal selected from titanium, zirconium, hafnium, iron (III), cobalt (III) or aluminium; L1 and L2 are each independently selected from a diketonate, an ester or amide of acetoacetic acid, a hydroxycarboxylic acid or ester thereof, R1COO— where R1 is substituted or unsubstituted C5-C30 branched or linear alkyl, substituted or unsubstituted aryl including polycyclic structures such as naphthyl or anthracyl, phosphate, phosphinate, phosphonate, siloxy or sulphonato, provided that when L1 is a ligand which forms two covalent bonds with the metal atom, and x=1 then y=0; L3 is selected from substituted or unsubstituted aryloxy, R2COO— where R2 is a linear or branched C6-C30 alkyl or a substituted or unsubstituted aryl, a polyoxyalkyl or hydroxyalkoxyalkylgroup; R is alkyl or hydroxy-alkyl hydroxyalkoxyalkyl, or (hydroxy)polyoxyalkyl group, x, y and z are each either 0 or 1 (x+y+z)≦V−1, where V=the valency of the metal M. The invention further concerns compositions and processes for the manufacture of polyurethane articles using the organometallic compounds as catalysts to provide cured articles having a comparable performance to those produced using a commercial mercury-based catalyst.
Abstract:
This invention discloses an illumination device for use in image reading applications. The illumination device comprises a light guide and a light source attached to one end of the light guide, which consists of a rod-shaped body with two end light reflectors made of metal clips. The two lateral surfaces of the light guide causes total internal reflection of light rays impinging upon the surface from within the light guide. The curved top surface of the light guide serves the function of focusing. The narrow bottom surface along the light guide reflects the light with a series of highly reflective paint stripes of varying widths applied upon it. The light source comprises a plurality of light emitting elements and at least a center of the light emitting elements is placed along a normal line passing through a center of the reflection area when viewed in a longitudinal direction of the light guide. A light beam applied from the light source is scattered and reflected by a scatter and reflection area of the light guide to illuminate an original document.
Abstract:
A mask is provided for administering medication, particularly asthmatic medication, to equine animals, particularly horses. The mask has a body that fits over the nostrils of the horse. An aerosolization chamber is secured to the body and opens into the interior thereof, and is supplied with misted medications such as from a metered dose inhaler, for inhalation by the animal. The mask and body is also provided with one or more exhalation ports, and a strap or band or the like for securing the body to the animals face overlying the nostrils.
Abstract:
The present disclosure relates to antibodies or fragments thereof that target at least one conformational epitope of a Notch 3 or mutant Notch 3 receptor; and compositions and methods of use thereof.
Abstract:
The present invention relates to anti-FGFR2 and FGFR4 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.